Geneplus-Beijing Co. Ltd.   Report issue

For profit Phase 3
Founded: Beijing China (2010)

Organization Overview

First Clinical Trial
2017
NCT03042000
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Geneplus-Beijing Co. Ltd.